Switch to:
Also traded in: Chile, Germany, Mexico

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 0.11
CVS's Cash to Debt is ranked lower than
89% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.75 vs. CVS: 0.11 )
Ranked among companies with meaningful Cash to Debt only.
CVS' s Cash to Debt Range Over the Past 10 Years
Min: 0.06  Med: 0.14 Max: 1.14
Current: 0.11
0.06
1.14
Equity to Asset 0.40
CVS's Equity to Asset is ranked higher than
54% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.37 vs. CVS: 0.40 )
Ranked among companies with meaningful Equity to Asset only.
CVS' s Equity to Asset Range Over the Past 10 Years
Min: 0.39  Med: 0.54 Max: 0.67
Current: 0.4
0.39
0.67
Interest Coverage 12.72
CVS's Interest Coverage is ranked lower than
57% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.95 vs. CVS: 12.72 )
Ranked among companies with meaningful Interest Coverage only.
CVS' s Interest Coverage Range Over the Past 10 Years
Min: 10.84  Med: 11.79 Max: 17.26
Current: 12.72
10.84
17.26
F-Score: 7
Z-Score: 3.74
M-Score: -2.50
WACC vs ROIC
9.17%
10.65%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 6.06
CVS's Operating margin (%) is ranked higher than
71% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.11 vs. CVS: 6.06 )
Ranked among companies with meaningful Operating margin (%) only.
CVS' s Operating margin (%) Range Over the Past 10 Years
Min: 5.46  Med: 6.30 Max: 6.91
Current: 6.06
5.46
6.91
Net-margin (%) 3.39
CVS's Net-margin (%) is ranked higher than
71% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.12 vs. CVS: 3.39 )
Ranked among companies with meaningful Net-margin (%) only.
CVS' s Net-margin (%) Range Over the Past 10 Years
Min: 3.12  Med: 3.39 Max: 3.76
Current: 3.39
3.12
3.76
ROE (%) 13.50
CVS's ROE (%) is ranked higher than
69% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 8.89 vs. CVS: 13.50 )
Ranked among companies with meaningful ROE (%) only.
CVS' s ROE (%) Range Over the Past 10 Years
Min: 9.14  Med: 11.33 Max: 15.81
Current: 13.5
9.14
15.81
ROA (%) 6.51
CVS's ROA (%) is ranked higher than
86% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.73 vs. CVS: 6.51 )
Ranked among companies with meaningful ROA (%) only.
CVS' s ROA (%) Range Over the Past 10 Years
Min: 5.46  Med: 6.20 Max: 8.21
Current: 6.51
5.46
8.21
ROC (Joel Greenblatt) (%) 59.55
CVS's ROC (Joel Greenblatt) (%) is ranked lower than
54% of the 24 Companies
in the Global Health Care Plans industry.

( Industry Median: 86.38 vs. CVS: 59.55 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
CVS' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 26.8  Med: 46.17 Max: 56.33
Current: 59.55
26.8
56.33
Revenue Growth (3Y)(%) 14.50
CVS's Revenue Growth (3Y)(%) is ranked higher than
57% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.30 vs. CVS: 14.50 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
CVS' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 7.7  Med: 12.05 Max: 16
Current: 14.5
7.7
16
EBITDA Growth (3Y)(%) 14.30
CVS's EBITDA Growth (3Y)(%) is ranked higher than
68% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.60 vs. CVS: 14.30 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
CVS' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: 2.4  Med: 13.95 Max: 44
Current: 14.3
2.4
44
EPS Growth (3Y)(%) 15.20
CVS's EPS Growth (3Y)(%) is ranked higher than
73% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: 6.30 vs. CVS: 15.20 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
CVS' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: 1.7  Med: 15.35 Max: 112.8
Current: 15.2
1.7
112.8
» CVS's 10-Y Financials

Financials (Next Earnings Date: 2016-02-09)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2015

CVS Guru Trades in Q1 2015

Caxton Associates 4,000 sh (New)
Richard Pzena 527,165 sh (New)
Joel Greenblatt 272,287 sh (+5183.02%)
Paul Tudor Jones 94,783 sh (+700.06%)
Jeremy Grantham 1,049,025 sh (+363.56%)
Manning & Napier Advisors, Inc 141,000 sh (+12.62%)
Ken Fisher 158,975 sh (+11.93%)
Tom Gayner 245,000 sh (+5.60%)
PRIMECAP Management 3,303,890 sh (+3.67%)
Ruane Cunniff 24,953 sh (unchged)
Westport Asset Management 192,090 sh (unchged)
Charles de Vaulx 915,821 sh (unchged)
Mairs and Power Sold Out
Ray Dalio Sold Out
Pioneer Investments 5,446,829 sh (-0.90%)
Jeff Auxier 95,999 sh (-1.84%)
Vanguard Health Care Fund 3,899,920 sh (-2.87%)
Mario Gabelli 1,438,163 sh (-3.43%)
RS Investment Management 478,044 sh (-3.77%)
Scott Black 100,312 sh (-7.23%)
NWQ Managers 1,173,665 sh (-8.83%)
John Rogers 84,095 sh (-10.23%)
James Barrow 304,950 sh (-13.61%)
Robert Olstein 57,000 sh (-24.00%)
Signature Select Canadian Fund 75,753 sh (-24.14%)
First Pacific Advisors 4,629,500 sh (-32.76%)
Steven Romick 4,146,600 sh (-33.33%)
Jeff Auxier 45,209 sh (-53.77%)
» More
Q2 2015

CVS Guru Trades in Q2 2015

Louis Moore Bacon 50,000 sh (New)
Steven Cohen 34,300 sh (New)
Jeremy Grantham 2,058,725 sh (+96.25%)
RS Investment Management 681,410 sh (+42.54%)
RS Investment Management 681,410 sh (+42.54%)
James Barrow 389,950 sh (+27.87%)
PRIMECAP Management 3,602,710 sh (+9.04%)
Tom Gayner 247,000 sh (+0.82%)
Pioneer Investments 5,490,251 sh (+0.80%)
Richard Pzena 527,265 sh (+0.02%)
Westport Asset Management 192,090 sh (unchged)
Charles de Vaulx 915,821 sh (unchged)
Steven Romick 4,146,600 sh (unchged)
Vanguard Health Care Fund 3,899,920 sh (unchged)
Robert Olstein 57,000 sh (unchged)
Ruane Cunniff 24,953 sh (unchged)
Caxton Associates Sold Out
First Pacific Advisors 4,621,500 sh (-0.17%)
Jeff Auxier 95,649 sh (-0.36%)
Scott Black 99,462 sh (-0.85%)
John Rogers 82,895 sh (-1.43%)
Ken Fisher 156,437 sh (-1.60%)
Mario Gabelli 1,359,978 sh (-5.44%)
NWQ Managers 819,859 sh (-30.15%)
Manning & Napier Advisors, Inc 88,230 sh (-37.43%)
Joel Greenblatt 91,217 sh (-66.50%)
Paul Tudor Jones 3,200 sh (-96.62%)
» More
Q3 2015

CVS Guru Trades in Q3 2015

Jim Simons 854,505 sh (New)
Mairs and Power 2,246 sh (New)
John Burbank 30,304 sh (New)
Louis Moore Bacon 123,000 sh (+146.00%)
Jeremy Grantham 2,397,897 sh (+16.47%)
RS Investment Management 714,365 sh (+4.84%)
Manning & Napier Advisors, Inc 88,230 sh (unchged)
Tom Gayner 247,000 sh (unchged)
Richard Pzena 527,265 sh (unchged)
Westport Asset Management 192,090 sh (unchged)
Ruane Cunniff 24,953 sh (unchged)
John Rogers Sold Out
Steven Cohen Sold Out
James Barrow 383,650 sh (-1.62%)
Manning & Napier Advisors, Inc 85,900 sh (-2.64%)
Signature Select Canadian Fund 72,453 sh (-4.36%)
NWQ Managers 783,473 sh (-4.44%)
PRIMECAP Management 3,408,820 sh (-5.38%)
Charles de Vaulx 840,664 sh (-8.21%)
Scott Black 89,505 sh (-10.01%)
Mario Gabelli 1,215,593 sh (-10.62%)
Pioneer Investments 4,893,987 sh (-10.86%)
Paul Tudor Jones 2,600 sh (-18.75%)
Vanguard Health Care Fund 3,084,020 sh (-20.92%)
Robert Olstein 45,000 sh (-21.05%)
Ken Fisher 122,805 sh (-21.50%)
Jeff Auxier 52,499 sh (-45.11%)
Joel Greenblatt 20,797 sh (-77.20%)
First Pacific Advisors 681,570 sh (-85.25%)
Steven Romick 507,110 sh (-87.77%)
» More
Q4 2015

CVS Guru Trades in Q4 2015

Richard Pzena 527,389 sh (+0.02%)
Vanguard Health Care Fund 3,084,020 sh (unchged)
Steven Romick Sold Out
Ken Fisher 122,308 sh (-0.40%)
Mario Gabelli 1,178,788 sh (-3.03%)
James Barrow 368,897 sh (-3.85%)
» More
» Details

Insider Trades

Latest Guru Trades with CVS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 20.94
CVS's P/E(ttm) is ranked lower than
55% of the 38 Companies
in the Global Health Care Plans industry.

( Industry Median: 21.01 vs. CVS: 20.94 )
Ranked among companies with meaningful P/E(ttm) only.
CVS' s P/E(ttm) Range Over the Past 10 Years
Min: 10.57  Med: 18.42 Max: 27.11
Current: 20.94
10.57
27.11
Forward P/E 14.25
CVS's Forward P/E is ranked lower than
69% of the 35 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.40 vs. CVS: 14.25 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 21.05
CVS's PE(NRI) is ranked lower than
53% of the 30 Companies
in the Global Health Care Plans industry.

( Industry Median: 21.13 vs. CVS: 21.05 )
Ranked among companies with meaningful PE(NRI) only.
CVS' s PE(NRI) Range Over the Past 10 Years
Min: 10.58  Med: 18.42 Max: 27.1
Current: 21.05
10.58
27.1
P/B 2.80
CVS's P/B is ranked lower than
71% of the 42 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.13 vs. CVS: 2.80 )
Ranked among companies with meaningful P/B only.
CVS' s P/B Range Over the Past 10 Years
Min: 1.01  Med: 1.78 Max: 3.38
Current: 2.8
1.01
3.38
P/S 0.71
CVS's P/S is ranked lower than
74% of the 42 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.47 vs. CVS: 0.71 )
Ranked among companies with meaningful P/S only.
CVS' s P/S Range Over the Past 10 Years
Min: 0.4  Med: 0.62 Max: 0.88
Current: 0.71
0.4
0.88
PFCF 17.44
CVS's PFCF is ranked lower than
74% of the 42 Companies
in the Global Health Care Plans industry.

( Industry Median: 12.68 vs. CVS: 17.44 )
Ranked among companies with meaningful PFCF only.
CVS' s PFCF Range Over the Past 10 Years
Min: 9.1  Med: 22.04 Max: 208.79
Current: 17.44
9.1
208.79
POCF 12.84
CVS's POCF is ranked lower than
80% of the 40 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.16 vs. CVS: 12.84 )
Ranked among companies with meaningful POCF only.
CVS' s POCF Range Over the Past 10 Years
Min: 6.73  Med: 13.80 Max: 35.82
Current: 12.84
6.73
35.82
EV-to-EBIT 14.05
CVS's EV-to-EBIT is ranked lower than
62% of the 42 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.30 vs. CVS: 14.05 )
Ranked among companies with meaningful EV-to-EBIT only.
CVS' s EV-to-EBIT Range Over the Past 10 Years
Min: 7.6  Med: 11.60 Max: 20.4
Current: 14.05
7.6
20.4
EV-to-EBITDA 11.52
CVS's EV-to-EBITDA is ranked lower than
76% of the 42 Companies
in the Global Health Care Plans industry.

( Industry Median: 8.47 vs. CVS: 11.52 )
Ranked among companies with meaningful EV-to-EBITDA only.
CVS' s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.2  Med: 9.40 Max: 16
Current: 11.52
6.2
16
PEG 1.95
CVS's PEG is ranked lower than
57% of the 14 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.45 vs. CVS: 1.95 )
Ranked among companies with meaningful PEG only.
CVS' s PEG Range Over the Past 10 Years
Min: 0.56  Med: 1.36 Max: 3.35
Current: 1.95
0.56
3.35
Shiller P/E 31.65
CVS's Shiller P/E is ranked lower than
63% of the 24 Companies
in the Global Health Care Plans industry.

( Industry Median: 26.74 vs. CVS: 31.65 )
Ranked among companies with meaningful Shiller P/E only.
CVS' s Shiller P/E Range Over the Past 10 Years
Min: 17.19  Med: 26.16 Max: 39.47
Current: 31.65
17.19
39.47
Current Ratio 1.43
CVS's Current Ratio is ranked higher than
64% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.23 vs. CVS: 1.43 )
Ranked among companies with meaningful Current Ratio only.
CVS' s Current Ratio Range Over the Past 10 Years
Min: 1.05  Med: 1.51 Max: 2.09
Current: 1.43
1.05
2.09
Quick Ratio 0.82
CVS's Quick Ratio is ranked lower than
73% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.12 vs. CVS: 0.82 )
Ranked among companies with meaningful Quick Ratio only.
CVS' s Quick Ratio Range Over the Past 10 Years
Min: 0.29  Med: 0.58 Max: 0.93
Current: 0.82
0.29
0.93
Days Inventory 36.36
CVS's Days Inventory is ranked lower than
82% of the 11 Companies
in the Global Health Care Plans industry.

( Industry Median: 5.26 vs. CVS: 36.36 )
Ranked among companies with meaningful Days Inventory only.
CVS' s Days Inventory Range Over the Past 10 Years
Min: 36.78  Med: 45.49 Max: 74.66
Current: 36.36
36.78
74.66
Days Sales Outstanding 31.32
CVS's Days Sales Outstanding is ranked lower than
62% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 26.48 vs. CVS: 31.32 )
Ranked among companies with meaningful Days Sales Outstanding only.
CVS' s Days Sales Outstanding Range Over the Past 10 Years
Min: 18.14  Med: 20.45 Max: 25.37
Current: 31.32
18.14
25.37
Days Payable 20.90
CVS's Days Payable is ranked lower than
69% of the 16 Companies
in the Global Health Care Plans industry.

( Industry Median: 49.48 vs. CVS: 20.90 )
Ranked among companies with meaningful Days Payable only.
CVS' s Days Payable Range Over the Past 10 Years
Min: 16.69  Med: 19.86 Max: 32.98
Current: 20.9
16.69
32.98

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.58
CVS's Dividend Yield is ranked lower than
52% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.63 vs. CVS: 1.58 )
Ranked among companies with meaningful Dividend Yield only.
CVS' s Dividend Yield Range Over the Past 10 Years
Min: 0.42  Med: 1.03 Max: 1.58
Current: 1.58
0.42
1.58
Dividend Payout 0.30
CVS's Dividend Payout is ranked higher than
58% of the 12 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.67 vs. CVS: 0.30 )
Ranked among companies with meaningful Dividend Payout only.
CVS' s Dividend Payout Range Over the Past 10 Years
Min: 0.08  Med: 0.15 Max: 1.87
Current: 0.3
0.08
1.87
Dividend Growth (3y) 30.10
CVS's Dividend Growth (3y) is ranked higher than
62% of the 8 Companies
in the Global Health Care Plans industry.

( Industry Median: 29.10 vs. CVS: 30.10 )
Ranked among companies with meaningful Dividend Growth (3y) only.
CVS' s Dividend Growth (3y) Range Over the Past 10 Years
Min: -13.6  Med: 12.85 Max: 37
Current: 30.1
-13.6
37
Forward Dividend Yield 1.83
CVS's Forward Dividend Yield is ranked higher than
52% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.76 vs. CVS: 1.83 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 6.14
CVS's Yield on cost (5-Year) is ranked higher than
50% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 5.95 vs. CVS: 6.14 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
CVS' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 1.63  Med: 4.00 Max: 6.14
Current: 6.14
1.63
6.14
3-Year Average Share Buyback Ratio 4.60
CVS's 3-Year Average Share Buyback Ratio is ranked higher than
91% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: -0.60 vs. CVS: 4.60 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
CVS' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -20.4  Med: -0.40 Max: 4.6
Current: 4.6
-20.4
4.6

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 1.12
CVS's Price/Projected FCF is ranked lower than
57% of the 42 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.03 vs. CVS: 1.12 )
Ranked among companies with meaningful Price/Projected FCF only.
CVS' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.82  Med: 2.13 Max: 13.38
Current: 1.12
0.82
13.38
Price/DCF (Earnings Based) 1.22
CVS's Price/DCF (Earnings Based) is ranked lower than
62% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.14 vs. CVS: 1.22 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.14
CVS's Price/Median PS Value is ranked lower than
78% of the 41 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.88 vs. CVS: 1.14 )
Ranked among companies with meaningful Price/Median PS Value only.
CVS' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.59  Med: 1.00 Max: 2.4
Current: 1.14
0.59
2.4
Price/Peter Lynch Fair Value 1.57
CVS's Price/Peter Lynch Fair Value is ranked higher than
59% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.60 vs. CVS: 1.57 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
CVS' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.63  Med: 1.38 Max: 3.68
Current: 1.57
0.63
3.68
Earnings Yield (Greenblatt) (%) 7.10
CVS's Earnings Yield (Greenblatt) (%) is ranked higher than
57% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 6.40 vs. CVS: 7.10 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
CVS' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 4.9  Med: 8.60 Max: 13.2
Current: 7.1
4.9
13.2
Forward Rate of Return (Yacktman) (%) 17.13
CVS's Forward Rate of Return (Yacktman) (%) is ranked higher than
56% of the 16 Companies
in the Global Health Care Plans industry.

( Industry Median: 16.60 vs. CVS: 17.13 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
CVS' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 6.7  Med: 16.50 Max: 24.2
Current: 17.13
6.7
24.2

More Statistics

Revenue(Mil) $149200
EPS $ 4.45
Beta1.06
Short Percentage of Float1.35%
52-Week Range $81.37 - 113.65
Shares Outstanding(Mil)1107.32

Analyst Estimate

Dec15 Dec16 Dec17
Revenue(Mil) 152,642 178,031 193,690
EPS($) 5.10 5.79 6.53
EPS without NRI($) 5.10 5.79 6.53

Latest Earnings Webcast

» More Conference Calls

Business Description

Industry: Health Care Plans » Health Care Plans
Compare:SHDMF, APNHF, GNC, JCOUF, PMC » details
Traded in other countries:CVS.Chile, CVS.Germany, CVS.Mexico,
CVS Health Corp, formerly known as CVS Caremark Corporation was incorporated in the State of Delaware. The Company is an integrated pharmacy health care provider in the United States. They have three segments: Pharmacy Services, Retail Pharmacy and Corporate. The pharmacy services segment provides pharmacy benefit management services, as described more fully below, to their clients consisting primarily of employers, insurance companies, unions, government employee groups, managed care organizations ("MCOs") and other sponsors of health benefit plans and individuals throughout the United States. They operate a network of mail service specialty pharmacies. There specialty pharmacies were comprised of 11 specialty mail order pharmacies located throughout the United States that are used for delivery of medications to individuals with chronic or genetic diseases and disorders. The retail pharmacy segment included 7,660 retail drugstores, of which 7,603 operated a pharmacy, their online retail pharmacy websites, CVS.com and Onofre.com.br, 17 onsite pharmacy stores and retail health care clinics. There corporate segment provides management and administrative services to support the operations of the company. The corporate Segment consists of certain aspects of executive management, corporate relations, legal, compliance, human resources, corporate information technology and finance departments. Its customers include managed care organizations and government-funded health care commercial employers. It competes with other drugstore chains like Walgreens and Rite Aid, supermarkets, discount retailers (e.g., Wal-Mart and Target), independent pharmacies, restrictive pharmacy networks, membership clubs, Internet companies and retail health clinics, as well as other mail order pharmacies and PBMs. The Company's business is subject to federal and state laws and regulations that govern the purchase, sale and distribution of prescription drugs and related services, including administration and management of prescription drug benefits.
» More Articles for NYSE:CVS

Headlines

Articles On GuruFocus.com
Mario Gabelli Comments on CVS Health Corp Feb 05 2016 
Steven Romick Sells Microsoft, Walgreens, CVS Jan 20 2016 
Louis Moore Bacon's Largest 3rd Quarter Trades Dec 23 2015 
First Pacific Advisors Slashes Stake in CVS Health Dec 17 2015 
Health Care Stocks Play Prominent Roles in Steven Romick's Transactions Dec 15 2015 
John Rogers Sells Position in CVS Dec 12 2015 
Taking a Look at Barron’s 10 Favorite Stocks for 2016 Dec 07 2015 
How the Walgreens-Rite Aid Deal Stacks Up Against Paulson's Merger Arbitrage Checklist Nov 05 2015 
Walgreens Buys Rite Aid to Avoid Loose Market Nov 04 2015 
How Rite Aid Deal Will Change Walgreens Oct 30 2015 

More From Other Websites
[$$] Free Snacks Fly Again at American Airlines Feb 06 2016
Bill Gates, Apple Chair, Nike CEO Lead Week’s Insider Trades Feb 05 2016
Stock Mutual Funds Could See Some Recovery By Midyear Feb 05 2016
Buy CVS Health Now and Feel Better About Its Earnings Feb 05 2016
25 Companies That Could Still Buy Back Mountains Of Stock Feb 04 2016
Rite Aid Shareholders OK Walgreen Deal As CVS Melds Target Pharmacies Feb 04 2016
2 sectors that will keep beating the market: Technician Feb 04 2016
Here's How 10 of the Biggest Stock 'Darlings' Did in January Feb 03 2016
Saperstein's value pick: CVS Feb 03 2016
CVS launches rebranding of Target Pharmacy Feb 03 2016
Target, CVS Pharmacy debut new co-branded pharmacy in Charlotte Feb 03 2016
Target opening CVS pharmacies in stores is scary news for consumers Feb 03 2016
Coverage initiated on CVS Health by Atlantic Equities Feb 03 2016
Urgent Care Market Braces For CVS And Walgreens Entry Feb 03 2016
CVS Health Introduces First CVS Pharmacy Locations within Target Stores Feb 03 2016
Q&A: CEOs of Target, CVS say pharmacy deal benefits both chains Feb 03 2016
CVS Opens First Pharmacies Within Target Stores Feb 03 2016
Technical Snapshot on Health Care Plans Stocks -- Express Scripts Holding, CVS Health, UnitedHealth... Feb 02 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK